Author
Listed:
- Somnath Mukherjee
(The University of Chicago)
- Satchal K. Erramilli
(The University of Chicago)
- Mark Ammirati
(Medicine Design, Worldwide Research and Development, Pfizer Inc.)
- Frances J. D. Alvarez
(Medicine Design, Worldwide Research and Development, Pfizer Inc.)
- Kimberly F. Fennell
(Medicine Design, Worldwide Research and Development, Pfizer Inc.)
- Michael D. Purdy
(University of Virginia School of Medicine)
- Blazej M. Skrobek
(The University of Chicago
Ludwig Maximilian University of Munich)
- Katarzyna Radziwon
(The University of Chicago
University of Wisconsin Madison)
- John Coukos
(The University of Chicago)
- Yanyong Kang
(Center for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute
Takeda San Diego Inc.)
- Przemysław Dutka
(The University of Chicago
California Institute of Technology)
- Xiang Gao
(Center for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute)
- Xiayang Qiu
(Medicine Design, Worldwide Research and Development, Pfizer Inc.)
- Mark Yeager
(University of Virginia School of Medicine)
- H. Eric Xu
(Center for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute
Center for Structure and Function of Drug Targets, Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
- Seungil Han
(Medicine Design, Worldwide Research and Development, Pfizer Inc.)
- Anthony A. Kossiakoff
(The University of Chicago
University of Chicago)
Abstract
We propose the concept of universal fiducials based on a set of pre-made semi-synthetic antibodies (sABs) generated by customized phage display selections against the fusion protein BRIL, an engineered variant of apocytochrome b562a. These sABs can bind to BRIL fused either into the loops or termini of different GPCRs, ion channels, receptors and transporters without disrupting their structure. A crystal structure of BRIL in complex with an affinity-matured sAB (BAG2) that bound to all systems tested delineates the footprint of interaction. Negative stain and cryoEM data of several examples of BRIL-membrane protein chimera highlight the effectiveness of the sABs as universal fiducial marks. Taken together with a cryoEM structure of sAB bound human nicotinic acetylcholine receptor, this work demonstrates that these anti-BRIL sABs can greatly enhance the particle properties leading to improved cryoEM outcomes, especially for challenging membrane proteins.
Suggested Citation
Somnath Mukherjee & Satchal K. Erramilli & Mark Ammirati & Frances J. D. Alvarez & Kimberly F. Fennell & Michael D. Purdy & Blazej M. Skrobek & Katarzyna Radziwon & John Coukos & Yanyong Kang & Przemy, 2020.
"Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins,"
Nature Communications, Nature, vol. 11(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15363-0
DOI: 10.1038/s41467-020-15363-0
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- David Jonathan Wasilko & Brian S. Gerstenberger & Kathleen A. Farley & Wei Li & Jennifer Alley & Mark E. Schnute & Ray J. Unwalla & Jorge Victorino & Kimberly K. Crouse & Ru Ding & Parag V. Sahasrabud, 2024.
"Structural basis for CCR6 modulation by allosteric antagonists,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Kaihua Zhang & Hao Wu & Nicholas Hoppe & Aashish Manglik & Yifan Cheng, 2022.
"Fusion protein strategies for cryo-EM study of G protein-coupled receptors,"
Nature Communications, Nature, vol. 13(1), pages 1-11, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15363-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.